While probing Johnson’s company, however, the Times was also able to get its hands on information concerning an internal ...
Johnson & Johnson, facing potential drug import tariffs from the Trump administration, will invest over $55 billion in the ...
Exclusive new testing by Consumer Reports highlights safer formulas while also identifying some that contain potentially ...
We really want these results to be empowering for parents,” said Consumer Reports, which tested 41 types of baby formula.
The Badgers women's hockey program is knocking on the door of its eighth national title. Its coach is well compensated, but a ...
Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for ...
Johnson & Johnson has been fighting thousands of lawsuits over its now-discontinued talc products for 16 years. A pending ...
Johnson & Johnson claims a federal judge wrongfully granted its investors class certification for losses related to purported ...
The cosmetics giant L'Oréal stuck a 'do not use' alert on its dermatologist-backed moisturiser. It is feared the product is ...
BofA raised the firm’s price target on Johnson & Johnson (JNJ) to $171 from $159 and keeps a Neutral rating on the shares. For the last ...
Thousands of families have filed Johnson & Johnson talcum powder lawsuits alleging the company’s talc products caused cancer. They claim J&J knew about the risk of asbestos in their talc-based baby ...
The Braves enter Spring Training with a luxury tax payroll around $230MM, according to the RosterResource calculations. That puts them about $11MM shy of the base threshold. Atlanta has paid the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results